Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Obstructive sleep apnea and levels of physical activity and its association with elevated cardiovascular risk in chilean adults Source: International Congress 2018 – Diagnostics including questionnaires Year: 2018
Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Obstructive sleep apnea, cardiometabolic risk, and levels of physical activity in Chilean adults Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea Year: 2017
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19 Source: Sleep and Breathing Conference 2021 Year: 2021
Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Obstructive sleep apnea is associated with an increased risk of occupational injuries and reduced work productivity Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Serum vitamin D levels are associated with markers of hypoxia in obstructive sleep apnea patients Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Serum midkine levels in patients with obstructive sleep apnea Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity? Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Obstructive sleep apnea-related fatigue and serum testosterone Source: Annual Congress 2013 –Sleep disordered breathing in special situations II Year: 2013
Determinant factors of serum leptin levels in patients with obstructive sleep apnea Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005